Evidence map›Paper›PMID 35474546›Full record

ArticlePediatrics2022

Antibiotic Use and Vaccine Antibody Levels.

Timothy J Chapman, Minh Pham, Peter Bajorski, Michael E Pichichero

Open access · greenAbstract read
In one paragraph

Article in Pediatrics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 29 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Variability of Vaccine Responsiveness in Young Children.The Journal of infectious diseases · 2024
    Article
  19. RETRACTED: Effect ofMicroorganisms · 2024
    Article
  20. Host microbiome-pathogen interactions in pediatric infections.Current opinion in infectious diseases · 2023
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Timothy J ChapmanCenter for Infectious Diseases and Immunology, Rochester General Hospital Research Institute, Rochester, New York.
Minh PhamSchool of Mathematical Sciences, College of Science, Rochester Institute of Technology, Rochester, New York.
Peter BajorskiSchool of Mathematical Sciences, College of Science, Rochester Institute of Technology, Rochester, New York.
Michael E PichicheroCenter for Infectious Diseases and Immunology, Rochester General Hospital Research Institute, Rochester, New York.
Rochester General Hospital · USRochester Institute of Technology · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe majority of children are prescribed antibiotics in the first 2 years of life while vaccine-induced immunity develops. Researchers have suggested a negative association of antibiotic use with vaccine-induced immunity in adults, but data are lacking in children.

methodsFrom 2006 to 2016, children aged 6 to 24 months were observed in a cohort study. A retrospective, unplanned secondary analysis of the medical record regarding antibiotic prescriptions and vaccine antibody measurements was undertaken concurrently. Antibody measurements relative to diphtheria-tetanus-acellular pertussis (DTaP), inactivated polio (IPV), Haemophilus influenzae type b (Hib), and pneumococcal conjugate (PCV) vaccines were made.

resultsIn total, 560 children were compared (342 with and 218 without antibiotic prescriptions). Vaccine-induced antibody levels to several DTaP and PCV antigens were lower (P < .05) in children given antibiotics. A higher frequency of vaccine-induced antibodies below protective levels in children given antibiotics occurred at 9 and 12 months of age (P < .05). Antibiotic courses over time was negatively associated with vaccine-induced antibody levels. For each antibiotic course the child received, prebooster antibody levels to DTaP antigens were reduced by 5.8%, Hib by 6.8%, IPV by 11.3%, and PCV by 10.4% (all P ≤ .05), and postbooster antibody levels to DTaP antigens were reduced by 18.1%, Hib by 21.3%, IPV by 18.9%, and PCV by 12.2% (all P < .05).

conclusionsAntibiotic use in children <2 years of age is associated with lower vaccine-induced antibody levels to several vaccines.

Indexed as

Diphtheria-Tetanus-acellular Pertussis VaccinesHaemophilus VaccinesAnti-Bacterial AgentsAntibodies, ViralChildChild, PreschoolCohort StudiesHumansPoliovirus Vaccine, InactivatedRetrospective StudiesVaccines, CombinedAnti-Bacterial AgentsAntibodies, ViralDiphtheria-Tetanus-acellular Pertussis VaccinesHaemophilus VaccinesPoliovirus Vaccine, InactivatedVaccines, Combined

Identifiers

PMID35474546
PMCPMC9648114
OpenAlexW4224949938

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.